Transforming growth factor-β1 preserves epithelial barrier function: Identification of receptors, biochemical intermediates, and cytokine antagonists

Journal of Cellular Physiology

Volumn 181, Issue 1, 1999, Pages 55-66

  Planchon, Sarah ^a   Fiocchi, Claudio ^b   Takafuji, Vivian ^a   Roche, James K ^a  

^a UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

^b UNIVERSITY HOSPITALS OF CLEVELAND   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

BUCLADESINE; GAMMA INTERFERON; INTERLEUKIN 10; INTERLEUKIN 4; INTERLEUKIN 6; ISOBUTYLMETHYLXANTHINE; PENTOXIFYLLINE; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

ARTICLE; CONTROLLED STUDY; CYTOKINE RELEASE; EPITHELIUM CELL; HUMAN; HUMAN CELL; IMMUNOMODULATION; INTESTINE EPITHELIUM; MEMBRANE PERMEABILITY; PRIORITY JOURNAL; RECEPTOR DENSITY; T LYMPHOCYTE ACTIVATION;

CYCLIC AMP; CYTOKINES; HOMEOSTASIS; HUMANS; IMMUNOHISTOCHEMISTRY; INTESTINAL MUCOSA; LYMPHOCYTE COUNT; RECEPTORS, CELL SURFACE; RECEPTORS, TRANSFORMING GROWTH FACTOR BETA; SIGNAL TRANSDUCTION; SOLUBILITY; T-LYMPHOCYTES; TRANSFORMING GROWTH FACTOR BETA;

EID: 0032813033     PISSN: 00219541     EISSN: None     Source Type: Journal    
DOI: 10.1002/(SICI)1097-4652(199910)181:1<55::AID-JCP6>3.0.CO;2-M     Document Type: Article

References (25)

1. Adams RB, Planchon SM, Roche JK. 1993. Gamma interferon modulation or epithelial barrier function: time course, reversibility and site of cytokine binding. J Immunol 150:2356-2363.
2. 2 of interleukin release by T lymphocytes in mucosa. J Cell Physiol 166:130-137.
3. Bull DM, Bookman MA. 1977. Isolation and functional characterization of human intestinal mucosal lymphoid cells. J Clin Invest 59:966-974.
4. Cerijido M, Robbins ES, Dolan WJ, Rotunno CA, Sabatini DD. 1978. Polarized monolayers formed by epithelial cells on a permeable and translucent support. J Cell Biol 77:853-867.
5. Colgan SP, Resniok MB, Parkos CA, Delp-Archeu C, McGuirk D, Bacarra AE, Weller PF, Madara JL. 1994. IL-4 directly modulates function of a model human intestinal epithelium. J Immunol 153: 2122-2129.
6. Dignass AU, Podolsky DK. 1993. Cytokine modulation of intestinal epithelial cell restitution: central role of transforming growth factor-β. Gastroenterology 105:1323-1332.
7. Fais S, Capobianchi MR, Pallone F, DiMarco P, Boirivant M, Dianzani F, Torsoli A. 1991. Spontaneous release of Interferon γ by intestinal lamina propria lymphocytes in Crohn's disease. Kinetics of in vitro response to interferon γ inducers. Gut 32:403-407.
8. Fiocchi C. 1990. Mucosal cellular immunity. In: Target SR, Shanahan E, editors. Immunology and immunopathology of the liver and the gastrointestinal tract. New York: Igaqu-Shoin Co. p 107-138.
9. Harvey J, Jones DB, Wright DH. 1989. Leucocyte common antigen expression on T cells in normal and inflamed gut. Immunology 68:13-17.
10. Heine J, Ignotz RA, Hemler ME, Crouse C, Massague J. 1989. Regulation of cell adhesion receptors by transforming growth factor-β. Concomitant regulation of integrins that share a common β1 subunit. J Biol Chem 264:380-388.
11. Hemesath TJ, Marton LS, Stefansson K. 1994. Inhibition of T cell activation by extracellular matrix protein tenascin. J Immunol 152: 5199-5207.
12. Ignotz RA, Massague J. 1986. Transforming growth factor-β stimulates the expression of fibronectin and collagen and their incorporation into the extracellular matrix. J Biol Chem 261:4337-4345.
13. Katz MS, Gutierrez GE, Mundy GR, Hymer TK, Caulfield MP, McKee RL. 1992. Tumor necrosis factor and interleukin 1 inhibit parathyroid hormone-responsive adenylate cyclase in clonal osteoblast-like cells by down-regulating parathyroid hormone receptors. J Cell Physiol 153:206-213.
14. MacDonald TT, Spencer JM. 1988. Evidence that activated mucosal T cells play a role in the pathogenesis of enteropathy in human small intestine. J Exp Med 167:1341-1349.
15. Madara JL, Stafford J. 1989. Interferon-gamma directly affects barrier function of cultured intestinal epithelial monolayers. J Clin Invest 83:724-727.
16. 1 renal epithelia to tumor necrosis factor. Am J Physiol 268:F315-F322.
17. Massague J. 1996. TGF-β signalling: receptors, transducers and Mad proteins. Cell 85:947-950.
18. Montesano R, Orci L. 1988. Transforming growth factor-β stimulates collagen-matrix contraction by fibroblasts: implications for wound-healing. Proc Natl Acad Sci USA 85:4894-4897.
19. 1) transepithelial permeability. Am J Physiol 263:F915-924.
20. Pietenpol JA, Hold JT, Stein RW, Moses HL. 1990. Transforming growth factor-β1 suppression of c-myc gene transcription: role in inhibition of keratinocyte proliferation. Proc Natl Acad Sci USA 87:3758-3762.
21. Planchon SM, Martins CAP, Guerrant RL, Roche JK. 1994. Regulation of intestinal epithelial barrier function by TGF-β1. Evidence for its role in abrogating the effect of a T cell cytokine. J Immunol 153:5730-5739.
22. Roche JK, Fiocchi C, Youngman K. 1985. Sensitization to epithelial antigens in chronic mucosal inflammatory disease. J Clin Invest 75:522-530.
23. Schreiber S, MacDermott RP, Raedler A, Pinnau R, Bertovich MJ, Nash GS. 1991. Increased activation of isolated intestinal lamina propria mononuclear cells in inflammatory bowel disease. Gastroenterology 101:1020-1030.
24. Trejdosiewcz LK, Smart CJ, Oakes DJ, Howdle PD, Malizia G, Campana D, Boylstons AW. 1989. Expression of T-cell receptors TcR1 (γ/δ) and TcR2 (α/β) in the human intestinal mucosa. Immunology 68:7-12.
25. Winsett MP, Ramsey JW, Barnard JA. 1996. Type II TGF-β receptor expression in intestinal cell lines and in the intestinal tract. Carcinogenesis 17:989-995.